blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4389152

EP4389152 - CONJUGATES OF PBD PRODRUGS [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  24.05.2024
Database last updated on 17.09.2024
Most recent event   Tooltip27.06.2024New entry: Despatch of communication that application is refused 
Applicant(s)For all designated states
Synaffix B.V.
Kloosterstraat 9
5349 AB Oss / NL
[2024/26]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2024/26]
Application number, filing date22216669.623.12.2022
[2024/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4389152
Date:26.06.2024
Language:EN
[2024/26]
Search report(s)(Supplementary) European search report - dispatched on:EP13.06.2023
ClassificationIPC:A61K47/68, A61P35/00
[2024/26]
CPC:
A61K47/6851 (EP); A61K47/68035 (EP); A61K47/6889 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/26]
Extension statesBANot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:KONJUGATE VON PBD-PRODRUGS[2024/26]
English:CONJUGATES OF PBD PRODRUGS[2024/26]
French:CONJUGUÉS DE PROMÉDICAMENTS DE PBD[2024/26]
Examination procedure27.06.2024Despatch of communication that the application is refused, reason: Examination on filing A.90(5) {1}
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2018146188  (MEDIMMUNE LTD [GB]);
 [X]WO2018146189  (ADC THERAPEUTICS SA [CH], et al);
 [A]WO2018146199  (ADC THERAPEUTICS SA [CH], et al);
 [X]WO2018193102  (ADC THERAPEUTICS SA [CH], et al);
 [X]WO2020127573  (ADC THERAPEUTICS SA [CH], et al);
 [XI]WO2021144313  (SYNAFFIX BV [NL]);
 [X]WO2021144314  (SYNAFFIX BV [NL]);
 [A]WO2021260232  (SYNAFFIX BV [NL]);
 [X]WO2022167689  (SYNAFFIX BV [NL]);
by applicantWO2012153193
 WO2013173391
 WO2014065661
 WO2014114207
 WO2016053107
 WO2016170186
 WO2019034764
 WO2020141923
 US2022218830
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.